Rockwell Medical, Inc. RMTI shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.

罗克韦尔医疗股份有限公司（RockwellMedical，Inc.）与透析产品和服务供应商签订产品购买协议后，RMTI股价周二在上市前上涨。

As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.

。

The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.

该协议预计将在第一年产生超过1000万美元的净销售额，其中一部分未包括在罗克韦尔医疗先前宣布的2025年收入估计中，随后几年价格将逐步上涨。

Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.

上周，该公司宣布将杰西·内里提升为首席财务官。

This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.

本月，罗克韦尔医疗公司（Rockwell Medical）披露了与HydroCare的合作关系，HydroCare将在透析水室购买并安装罗克韦尔的DAMX45干酸浓缩液混合系统。

This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.

预计该装置将推动罗克韦尔干酸血液透析浓缩液的新销售。

Also, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.

此外，上个月，该公司与Nephro集团透析中心签订了分销协议。

Price Action: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.

价格走势：周二最后一次检查时，RMTI股价上涨14.4%，报2.29美元。

Read Next:

阅读下一页：

Asia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept

亚洲股市大多下跌，欧洲股市上涨，因美元在美联储决定利率之前走强——今天全球市场在美国睡觉的时候

Image via Shutterstock.Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

通过Shutterstock拍摄图像。Benzinga API为您带来的市场新闻和数据©2024 Benzinga.com。Benzinga不提供投资建议。保留所有权利。